← Evidence map

ReviewMolecular cancer2025

Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.

Chao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40887613